Stockreport

Virios Therapeutics Announces Second Quarter 2024 Financial Results [Yahoo! Finance]

Virios Therapeutics, Inc.  (VIRI) 
PDF - Top-line results from the Bateman Horne Center's Long-COVID phase 2a study expected in October 2024, will provide key insights into final design of planned Phase 2b s [Read more]